FDA Inspection 825642 — Biomat USA Inc

Biomat USA Inc — FEI 3003190471

The FDA completed an inspection of Biomat USA Inc on Apr 3, 2013 in Beaumont, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 3, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Beaumont, TX (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation
6721 CFR 606.65(e)Following manufacturer's instructions
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs